This state-of-the-science Webinar detailed and disseminated information related to the diagnosis and management of fetal and neonatal alloimmune thrombocytopenia (FNAIT). The Webinar featured a leading expert in the area of immune thrombocytopenia, Dr. Jim Bussel, who listened to the presentation of two current cases and then provided an overview of the necessary diagnostic testing when FNAIT is suspected as well as the recent recommendations for FNAIT management and treatment. The case presentations and discussion were followed by a brief Q & A with the audience. In addition, special focus was paid to the maternal and fetal considerations professionals must address in making evidence-based decisions, as well as described the ways in which collaboration with obstetrics/gynecology augments management.
At the conclusion of this Webinar, participants will be able to:
Understand the importance of, and apply to practice, assessing and monitoring patients for the identification of FNAIT
Discuss and describe the potential maternal and fetal consequences of FNAIT and the considerations professionals must address in making decisions regarding management
Describe new, effective approaches to diagnosis, testing, assessment in order to improve fetal, neonatal and maternal outcomes
Describe the ways intersection of obstetrics and hematology augments management
